| Essam R Awad, MD | |
|
1030 President Ave, Suite 210, Fall River, MA 02720-5923 | |
| (508) 973-1780 | |
| (508) 973-0359 |
| Full Name | Essam R Awad |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 46 Years |
| Location | 1030 President Ave, Fall River, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659428480 | NPI | - | NPPES |
| EA04775 | Medicaid | RI | |
| 110053347A | Medicaid | MA |
| Facility Name | Location | Facility Type |
|---|---|---|
| Southcoast Hospitals Group | Fall river, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Southcoast Physicians Group Inc | 0749171957 | 746 |
News Archive
Wearing masks and quarantining while sick has helped mitigate the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). An indirect benefit of these efforts appears to be a decrease in flu cases and other respiratory infections. New research led by Lisa G. Winston of the University of California, San Francisco, confirmed COVID-19 public health interventions helped decrease the number of airborne viruses.
Kaiser Health News: "Federal officials plan to announce Tuesday a national strategy designed to ramp up and better coordinate the government's attack on the country's HIV/AIDS epidemic." Many HIV/AIDS advocates "say many more resources need to be committed to fight the disease, especially considering it doesn't get the attention it once did.
Addex Pharmaceuticals has announced that it has completed the first part of a two-part Phase I clinical trial to evaluate the newly developed modified release formulation of ADX48621. ADX48621 is scheduled to start a Phase IIa proof of concept study for the treatment of levodopa associated dyskinesia in Parkinson's disease during the first half of 2009.
PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, today announced the introduction of a new oncology testing service.
Synthesizing useful new compounds is what pharmaceutical discovery and development is all about. Researchers at the School of Science at Indiana University-Purdue University Indianapolis have devised a method to substantially speed up the process.
› Verified 1 days ago
| Entity Name | Southcoast Physicians Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336137629 PECOS PAC ID: 0749171957 Enrollment ID: O20040920000138 |
News Archive
Wearing masks and quarantining while sick has helped mitigate the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). An indirect benefit of these efforts appears to be a decrease in flu cases and other respiratory infections. New research led by Lisa G. Winston of the University of California, San Francisco, confirmed COVID-19 public health interventions helped decrease the number of airborne viruses.
Kaiser Health News: "Federal officials plan to announce Tuesday a national strategy designed to ramp up and better coordinate the government's attack on the country's HIV/AIDS epidemic." Many HIV/AIDS advocates "say many more resources need to be committed to fight the disease, especially considering it doesn't get the attention it once did.
Addex Pharmaceuticals has announced that it has completed the first part of a two-part Phase I clinical trial to evaluate the newly developed modified release formulation of ADX48621. ADX48621 is scheduled to start a Phase IIa proof of concept study for the treatment of levodopa associated dyskinesia in Parkinson's disease during the first half of 2009.
PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, today announced the introduction of a new oncology testing service.
Synthesizing useful new compounds is what pharmaceutical discovery and development is all about. Researchers at the School of Science at Indiana University-Purdue University Indianapolis have devised a method to substantially speed up the process.
› Verified 1 days ago
| Entity Name | Southcoast Hospitals Group, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306871223 PECOS PAC ID: 1850282310 Enrollment ID: O20041214000621 |
News Archive
Wearing masks and quarantining while sick has helped mitigate the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). An indirect benefit of these efforts appears to be a decrease in flu cases and other respiratory infections. New research led by Lisa G. Winston of the University of California, San Francisco, confirmed COVID-19 public health interventions helped decrease the number of airborne viruses.
Kaiser Health News: "Federal officials plan to announce Tuesday a national strategy designed to ramp up and better coordinate the government's attack on the country's HIV/AIDS epidemic." Many HIV/AIDS advocates "say many more resources need to be committed to fight the disease, especially considering it doesn't get the attention it once did.
Addex Pharmaceuticals has announced that it has completed the first part of a two-part Phase I clinical trial to evaluate the newly developed modified release formulation of ADX48621. ADX48621 is scheduled to start a Phase IIa proof of concept study for the treatment of levodopa associated dyskinesia in Parkinson's disease during the first half of 2009.
PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, today announced the introduction of a new oncology testing service.
Synthesizing useful new compounds is what pharmaceutical discovery and development is all about. Researchers at the School of Science at Indiana University-Purdue University Indianapolis have devised a method to substantially speed up the process.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Essam R Awad, MD 200 Mill Rd Ste 180, Fairhaven, MA 02719-5255 Ph: (508) 973-2000 | Essam R Awad, MD 1030 President Ave, Suite 210, Fall River, MA 02720-5923 Ph: (508) 973-1780 |
News Archive
Wearing masks and quarantining while sick has helped mitigate the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). An indirect benefit of these efforts appears to be a decrease in flu cases and other respiratory infections. New research led by Lisa G. Winston of the University of California, San Francisco, confirmed COVID-19 public health interventions helped decrease the number of airborne viruses.
Kaiser Health News: "Federal officials plan to announce Tuesday a national strategy designed to ramp up and better coordinate the government's attack on the country's HIV/AIDS epidemic." Many HIV/AIDS advocates "say many more resources need to be committed to fight the disease, especially considering it doesn't get the attention it once did.
Addex Pharmaceuticals has announced that it has completed the first part of a two-part Phase I clinical trial to evaluate the newly developed modified release formulation of ADX48621. ADX48621 is scheduled to start a Phase IIa proof of concept study for the treatment of levodopa associated dyskinesia in Parkinson's disease during the first half of 2009.
PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, today announced the introduction of a new oncology testing service.
Synthesizing useful new compounds is what pharmaceutical discovery and development is all about. Researchers at the School of Science at Indiana University-Purdue University Indianapolis have devised a method to substantially speed up the process.
› Verified 1 days ago
Stephen Zuehlke, M.D. Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 289 Pleasant St, Suite 301, Fall River, MA 02721 Phone: 508-679-9955 Fax: 508-679-1435 | |
Terence J Mcgovern, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1030 President Ave, Suite 210, Fall River, MA 02720 Phone: 508-973-1780 Fax: 508-973-0359 | |
Raju Singla, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 289 Pleasant St, Fall River, MA 02721 Phone: 508-646-7730 Fax: 508-672-0885 | |
Ronald Bruce Goodspeed, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 363 Highland Ave, Fall River, MA 02720 Phone: 508-679-7013 | |
Linsey Philip, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 277 Pleasant St, Suite 306, Fall River, MA 02721 Phone: 508-675-3232 Fax: 508-675-4942 | |
Dr. Tricia A Carty, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 534 Prospect St, Fall River, MA 02720 Phone: 508-973-7766 Fax: 508-973-7753 | |
Dr. Nick Mucciardi, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1030 President Ave, Suite 210, Fall River, MA 02720 Phone: 508-973-1780 Fax: 508-973-0359 |